Background/Aims: Atherosclerosis is a chronic inflammatory disease in the artery walls. Fibrinopeptide A (FPA) is a biomarker of the activation of coagulation system, and a high concentration of FPA in blood occurs in patients with ischemic heart disease etc. However, there exist few studies on the pathological effects of FPA in cardiovascular system. Therefore, the present study examined the effect of FPA on CRP expression in VSMCs and the molecular mechanisms. Methods: mRNA and protein expression was identified by quantitative real-time PCR and Western blot, respectively. Reactive oxygen species (ROS) and the immunofluorescence staining were observed by a fluorescence microscope. Plasma FPA and CRP level was determined by ELISA. Results: FPA induced the expressions of CRP, IL-1β and IL-6 in VSMCs, and anti-IL-1β and anti-IL-6 neutralizing antibodies partially reduced FPAinduced CRP expression in VSMCs. The subchronic administration of FPA to rats increased FPA level in plasma and CRP expression in the aortic artery walls. The further studies showed that FPA promoted superoxide anion generation in VSMCs. Antioxidant NAC antagonized FPA-stimulated superoxide anion generation and inhibited FPA-induced CRP expression in VSMCs. FPA activated ERK1/2 and p38 phosphorylation, and PD98059 and SB203580 reduced FPA-induced CRP expression. Moreover, NAC inhibited the activation of ERK1/2 and p38. In addition, FPA enhanced NF-κB level in the nuclei of VSMCs, and PDTC reduced FPA-induced expression of CRP. Conclusions: FPA induces CRP expression in VSMCs via ROS-ERK1/2/p38-NF-κB signal pathway. This finding for the first time provides an experimental evidence for pro-inflammatory effect of FPA.
Introduction
Atherosclerosis is a disease associated with chronic inflammation in the artery wall and inflammation is involved in the different phases of the disease from the plaque formation to the plaque rupture [1, 2] . Data from the clinical and experimental researches show that inflammatory markers like cytokines, acute-phase response proteins and cellular adhesion molecules are able to predict the event of atherosclerosis [3] . As an acute-phase response protein, C-reactive protein (CRP) is considered as an independent risk factor of atherosclerosis. CRP is not only a predictor of atherosclerosis but also plays a pivotal role in the progression of atherosclerosis [4] . CRP regulates the activities and expressions of many factors participating in atherogenesis [5] , such as evoking interleukin-6 and endothelin-1 releases [6] , inducing the expressions of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) [7] ; promoting the uptake of low-density lipoprotein by macrophage and stimulating the migration and proliferation of vascular smooth muscle cells (VSMCs) [8] .
VSMCs are involved in the whole progress of atherosclerosis, especially in the plaque formation [9] [10] [11] [12] . Although the circulating CRP is mainly from hepatocytes and nonhepatocytes including neurons, renal epithelium and respiratory tract, a growing evidence has identified that VSMCs also produce CRP [13, 14] . Moreover, the locally produced CRP in the vessel wall may play a direct and key role in the progress of atherosclerosis and cardiovascular complications.
The earlier studies showed that fibrinogen and its degradation products are involved in the development of atherosclerosis by mediating inflammatory responses and participating in thrombosis formation [15] [16] [17] [18] [19] . Fibrinopeptide A (FPA) is a peptide of 16 amino acids which occurs as a natural consequence of hemostasis from proteolysis of fibrinogen's Aα chain [20] . The peptide exists in blood of normal healthy individuals at the concentration of 0.5-2.0 nM, and is 2-10 time higher in blood of the patients with thrombotic disease , pulmonary embolism and acute ischemic cardiovascular disease [21] [22] [23] [24] [25] [26] . Surprisingly, so far there have been few studies on the biological activity of FPA. The limited reports show that FPA causes an irreversible damage to endothelial cells [27] , stimulates the secretions of IL-8, MCP-1, macrophage migration inhibitory factor and serpin E1 in dermal microvascular endothelial cells [28] ; promotes an infiltration of leukocytes and the production of the proinflammatory cytokine MCP-1 in the inflammation site after the injection into BALB/C mice [29] . In the present research, we examined the effect of FPA on CRP expression in VSMCs and probed whether reactive oxygen species (ROS), mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signal pathway played a role in FPA-induced CRP expression.
Materials and Methods

Reagents
Dulbecco's High Glucose Modified Eagles Medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco BRL (Grand Island, NY, USA). FPA, PD98059, SB203580, SP600125, N-acetylcysteine (NAC), pyrrolidine dithiocarbamate (PDTC), thenoyltrifluoroacetone (TTFA) and diphenyleneiodonium (DPI) were from Sigma-Aldrich (St. Louis, MO, USA). Rabbit polyclonal CRP antibody and mouse α-smooth muscle actin antibody were provided by Abcam (Cambridge, MA, USA). Rabbit monoclonal β-actin antibody was ordered from Zhuangzhi Biotech (Xi'an, China). NF-κB activation and nuclear translocation kits, 2',7'-dichlorodihydrofluororescein diacetate (H 2 DCF-DA), ERK1/2 and phospho-ERK1/2 antibodies were obtained from Beyotime (Jiangsu, China). Phospho-p38 and p38 antibody were from Cell Signaling Technology (Danvers, MA, USA). Relative second antibodies were provided by CW Biotech (Beijing, China). Rabbit monoclonal lamin B1 antibody was from Abnova (Taipei, Taiwan, China). Anti-rat IL1β and anti-rat IL-6 neutralizing antibodies were ordered from R&D Systems (MN, USA). ELISA kits for detecting IL-1β and IL-6, and for assay of FPA were from West Tang (Shanghai, China) and MLBIO Biotech (Shanghai, China) respectively.
Culture of rat VSMCs
The primary VSMCs separated from the thoracic aorta of male Sprague Dawley (SD) rats were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin and 100 U/ml streptomycin at 37℃ in a 5% CO 2 incubator as previously described [30, 31] . The cells showed the typical "hill and valley" morphology and 99% purity as identified by the immunofluorescence staining with α-smooth muscle-actin antibody (showed in Fig 1) . The cells between passages 3 and 8 were used in the present study. The cells were incubated in the serum-free medium for an additional 12 h before the experiments. All experimental procedures were strictly performed according to the international, national and institutional rulers, and approved by the Institutional Animal Care Committee of Xi'an Jiaotong University.
Assessment of the viability of VSMCs by the MTT methods.
VSMCs were incubated with 10 -4 -1.0 μM FPA for 12 h or with 10 -2 μM FPA for 0-24 h. Then, 20 μl MTT (5 mg/ml, Invitrogen, Carlsbad, CA, USA) was added to each well. After the incubation at 37℃ for 4 h, the culture medium was carefully removed and the formed formazan crystal was dissolved in 150 μl DMSO (Sigma-Aldrich, St. Louis, MO, USA) with vigorous shaking for 10 min. Finally, the optical density was determined at 490 nm with micro-plate reader (Bio-Rad, Hercules, CA, USA).
Quantitative real-time PCR
Total RNA was extracted from VSMCs using RNAfast100 purification kit (Xianfeng Biotech, Shaanxi, China). Complementary DNA (cDNA) was synthesized from total RNA (2 μg) by Revert Aid TM First Strand cDNA synthesis kit (TaKaRa, Tokyo, Japan) in accordance with the method provided by the manufacturer. Amplification of cDNA was accomplished by primer pairs specific for rat (showed in Table 1 ). Quantitative real-time PCR was performed using Agilent MX3000 Real-Time PCR System (Santa Clara, CA, USA). The reaction products were measured by detecting the binding of SYBR Green I to DNA using SYBR Green PCR Master Mix (Roche, Basel, Switzerland). Optimization of the amplification reaction was assured by a dissociation curve analysis. All samples were run in triplicate, and then analyzed using the 2 -ΔΔCt methods. The level of mRNA was expressed as relative to internal control GAPDH.
Western blot
VSMCs were washed 3 times with the ice-cold PBS after the treatments. The whole cell lysates were acquired using the lysis buffer supplemented with protease inhibitor cocktail and phosphatase inhibitors (Roche, Basel, Switzerland). Concentration of the protein was measured by BCA protein assay kit (Bio-Rad, Hercules, CA, USA). Equal amount of the protein (40 μg) was loaded, separated by 10% SDS-PAGE, and blotted onto PVDF membrane (0.45 μm, GE Healthcare, Buckinghamshire, UK). The membranes were incubated with anti-CRP (1:800 dilution), anti-β-actin (1:2000 dilu- antibodies at 4℃ overnight. After washed three times, the membranes were incubated with the relevant second antibodies (1:3000 dilution) for 1.5 h and then the immune complexes were enhanced by chemiluminescence.
Enzyme-linked immunosorbent assay (ELISA)
VSMCs were cultured in 96-well plate and stimulated with 10 -3 -1.0 μM FPA for 12 h or with 10 -2 μM FPA for the indicated time. Then, the supernatant was collected for assaying levels of IL-1β and IL-6 by ELISA kit specific for rat IL-1β and IL-6.
Neutralizing experiment
VSMCs were pretreated with anti-IL-1β and anti-IL-6 neutralizing antibodies (5 μg/ml) alone or in combination for 1 h and then stimulated with FPA (10 -2 μM) for additional 12 h. Finally, CRP protein expression was detected by western blot.
Determination of CRP expression in VSMCs and in the vessel wall with the immunofluorescence staining
In the in vitro experiment, VSMCs were incubated with the primary mouse anti-smooth muscle-actin antibody and with the secondary cy3 conjugated antibody for the identification of VSMCs after the cells were fixed and blocked. Next, the cells were treated with the primary rabbit anti-CRP antibody and with the secondary Alexa fluor 488 conjugated antibody for the staining of CRP. Subsequently, the cells were stained in the 2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI) solution. Each step above was followed by washing three times. Finally, the cells on the coverslips were preserved in anti-fade mounting medium and CRP expression was observed under fluorescent microscope (Olympus Tokyo, Japan).
In the in vivo experiment, the aortic artery was immediately isolated after blood samples were collected. Frozen sections (5 μm) were incubated with rabbit anti-CRP antibody (1:50 dilution) and mouse anti-smooth muscle actin antibody (1:100 dilution) at 4℃ overnight. After washed three times, the sections were incubated with goat anti-rabbit IgG (Alexa Fluor 488 conjugated) and goat anti-mouse IgG (Cy3 conjugated) antibodies for 30 min at 37 ℃ followed by the DAPI (10 mg/ml) staining for 3 min at 37℃. Finally, the sections were observed under fluorescence microscope (Olympus, Tokyo, Japan).
Measurement of superoxide anion generation in VSMCs
VSMCs were exposed to FPA (10 -2 μM) for 3 h after the pretreatment with NAC (10 4 μM), TTFA (10 μM), DPI (10 μM) for 1h. Then, the cells were loaded with H 2 DCF-DA (10 μM) for 1 h and washed with PBS three times. Fluorescence images were acquired at the excitation wavelength of 488 nm and the emission wavelength of 525 nm with fluorescence microscope (Olympus, Tokyo, Japan). Fluorescence intensity was measured and analyzed from the fluorescence images with the Image-pro plus software (Version X; Media Cybernetics, Silver Springs, MD, USA). The relative fluorescence intensity was taken as the average of values from six repeated experiments.
Assay of NF-κB activation in VSMCs by the immunofluorescence staining
VSMCs were incubated with the primary rabbit anti-NF-κB p65 antibody at 4℃ overnight, and then with the secondary Cy3-labeled antibody for 3 h at 37℃. The cells were stained in DAPI (10 mg/ml) for 3 min at 37℃. Finally, the cells on the coverslips were preserved in anti-fade mounting medium, and the activated NF-κB subunit p65 was observed under fluorescent microscope (Olympus, Tokyo, Japan).
Animal model
To observe whether FPA induces CRP generation in vascular smooth muscle tissue in vivo, a model of rat with the high level of blood FPA was established. Male SD rats (n = 16, weight: 180-220 g) were randomly assigned to the model and control groups [32, 33] . The rats in the model group were subcutaneously delivered with 17.0 μg/kg/h FPA (dissolved in normal saline) for 14 days through the implanted osmotic mini-pumps (Model 2004, ALZET, Cupertino, CA, USA). Rats in control group received normal saline in the same way as the model group. At the end of the experiment, rats were sacrificed under the deep anesthesia with chloral hydrate. Blood samples were collected via the abdominal aorta for measuring plasma FPA and 
Statistical analysis
Data were shown as means ± SEM. Statistical significance between two groups was tested by Student's t test. Statistical significance between multiple groups was assessed by one-way ANOVA followed by Tukey's test. All statistical analyses were performed by the GraphPad Prism (Version 6; La Jolla, CA, USA). p < 0.05 was considered to be statistically significant. Fig. 2A showed that FPA from 10 -4 μM to 1.0 μM did not produce a significant effect on the viability of VSMCs. Similarly, incubation of VSMCs with 10 -2 μM FPA for 6 to 24 h did not affect the viability of VSMCs (Fig. 2B) .
Results
Effect of FPA on the viability of VSMCs
FPA stimulates CRP expression in VSMCs
The results in Fig. 3 displayed that stimulation of VSMCs with FPA at 10 -2 to 1.0 μM for 12 h increased mRNA and protein expression of CRP in VSMCs in a concentrationdependent manner (Fig. 3A and 3B) . Incubation of VSMCs with 10 -2 μM FPA for 6 to 24 h upregulated mRNA and protein expression of CRP in VSMCs in a time-dependent way. Compared with control, mRNA and protein expression of CRP was obviously increased at 6 h and 12 h respectively ( Fig. 3C and 3D) . The immunofluorescence staining showed that there was a weakly positive staining of CRP in control VSMCs. However, treatment of the cells with 10 -2 μM FPA for 12 h up-regulated CRP expression in VSMCs in comparison with control (Fig. 4) . 
FPA increases IL-1β and IL-6 expressions in VSMCs
In order to further ensure the pro-inflammatory effect of FPA on VSMCs, we observed effect of FPA on the expressions of IL-1β and IL-6 in VSMCs. The results showed that FPA increased both IL-1β and IL-6 mRNA expressions in VSMCs and IL-1β and IL-6 levels in the supernatant of the cultured VSMCs in concentration-and time-depended fashions (Fig. 5) . 
Effect of anti-IL-1β and anti-IL-6 neutralizing antibodies on FPA-induced CRP expression in VSMCs
It is known that IL-1β and IL-6 stimulate CRP expression in VSMCs [34] , and FPA-induced CRP expression in VSMCs is possibly attributed to the release of IL-1β and IL-6. So, we conducted the neutralizing experiment to identify whether FPA directly induced CRP expression in VSMCs. As shown in Fig. 6 , anti-IL-1β and anti-IL-6 neutralizing antibodies alone or in combination did not alter FPA-induced expression of CRP in VSMCs. The result suggests that FPA directly induces CRP expression in VSMCs.
ROS are involved in FPA-induced CRP expression in VSMCs
As seen from Fig. 7A , the production of superoxide anion was significantly increased after the incubation of VSMCs with FPA. However, pre-incubation of the cells with TTFA (complex II inhibitor), DPI (NADPH oxidase inhibitor) and antioxidant NAC reduced FPA-induced production of superoxide anion in VSMCs. The further study indicated that NAC nearly abolished FPA-induced CRP expression in VSMCs (Fig. 7B) , suggesting that ROS are involved in FPAinduced CRP expression. Fig. 8A and 8B exhibited that pretreatment of VSMCs with PD98059 (ERK1/2 inhibitor) and SB203580 (p38 inhibitor) weakened FPA-induced expression of CRP. Although JNK inhibitor SP600125 mildly reduced FPA-induced CRP expression, there was no significant statistical difference in CRP expression compared with FPA alone (Fig. 8C) , indicating that FPA induces CRP expression in VSMCs via ERK1/2 and p38 pathway. Results from three independent experiments were expressed as mean ± SEM. **p<0.01 vs. control. Cellular
FPA induces CRP expression in VSMCs via ERK1/2/p38 pathway
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FPA induces CRP expression in VSMCs through the ROS-ERK1/2/p38 signal pathway
In order to clarify the relationship between ROS and ERK1/2/p38 pathways in FPA-induced CRP expression, VSMCs were pretreated with antioxidant NAC, ERK1/2 inhibitor PD98059 or p38 inhibitor SB203580 before stimulated with FPA at 10 -2 μM. Then, the phosphorylation of ERK1/2 and p38 was detected. The results showed that FPA activated the phosphorylation of ERK1/2 and p38 in VSMCs, while NAC, PD98059 and SB203580 decreased the expressions of the phosphorylated ERK1/2 and p38. These implicate that FPA induces CRP expression through the ROS-ERK1/2/p38 signal pathway (Fig. 9) .
NF-κB mediates FPA-induced CRP expression in VSMCs
Western blot analysis showed that FPA enhanced NF-κB level in the nuclei of VSMCs (Fig.  10A) . The immunofluorescence staining revealed that fluorescence for the cytosolic NF-κB was stronger in FPA-treated cells than control cells (Fig. 10B) , suggesting that more NF-κB is activated in the cytoplasm of VSMCs. The further experiment manifested that pretreatment of VSMCs with NF-κB inhibitor PDTC reduced FPA-induced expression of CRP (Fig. 10C) , verifying NF-κB-mediated CRP expression induced by FPA in VSMCs.
FPA stimulates CRP expression in vascular smooth muscle of rats
The results from the in vivo experiment showed that the subchronic administration of FPA to rats for 14 days obviously increased FPA (Fig. 11A) and CRP concentrations . FPA induces CRP expression in VSMCs through the ROS-ERK1/2/ p38 signal pathway. The cells were pretreated with NAC, PD98059 or SB203580 for 1 h before the incubation with FPA at 10 -2 μM for 1.5 h. Then, the phosphorylation of ERK1/2 and p38 was detected by western blot. Data from three independent experiments were expressed as mean ± SEM. ** p<0.01 vs. control, ## p<0.01 vs. FPA alone.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry in plasma (Fig.11B ) and CRP expression in the aortic artery walls of rats (Fig. 11C) . The immunohistochemical staining exhibited that a weak staining of CRP existed in the aortic artery walls of control rats. However, CRP expression was potently increased in the aortic artery walls of FPA-treated rats (Fig. 11E) . The images of CRP and α-actin coexisting The right panels were the merged field of red (for α-actin) and green (for CRP), and purple color represented the cell nucleus. Results were expressed as mean ± SEM (n = 6). **p<0.01 vs. model.
Cellular Physiology and Biochemistry indicated that VSMCs were a possible origin of CRP (Fig. 11E, merged panels) . In addition, FPA enhanced levels of the phosphorylated ERK1/2 and p38 in the aortic artery walls of rats (Fig. 11D) .
Discussion
Atherosclerosis is a common cardiovascular disease and the main pathological basis of the ischemic cardiocerebrovascular diseases. Although the pathogenesis of atherosclerosis is not well defined, more and more evidence supports that atherosclerosis is a chronic inflammatory disease in the artery walls. The inflammation plays an important role in the formation and progression of atherosclerosis. Among the multiple inflammatory factors, CRP is regarded as a representative molecule. The clinical observations find that a high level of FPA in blood means the activation of coagulation system [35] and occurs in the patients with venous thrombosis, pulmonary embolism and ischemic heart disease as a biomarker. However, few reports on the pathological effects of FPA in the cardiovascular system are indexed in literature. Therefore, the present study examined the pro-inflammatory effect of FPA on VSMCs and the molecular mechanisms. The results showed that FPA stimulated mRNA and protein expressions of CRP, IL-1β and IL-6 in VSMCs in vitro, and anti-IL-1β or anti-IL-6 neutralizing antibody alone or in combination did not change FPA-induced protein expression of CRP in VSMCs. The animal experiment confirmed that the subchronic administration of FPA to rats increased FPA and CRP levels in plasma and CRP expression in the aortic artery walls. These results suggest that FPA is not simply a biomarker of the coagulation activation, but also produces a pro-inflammatory effect on VSMCs by stimulating CRP, IL-1β and IL-6 expressions.
ROS are both the important second messenger and the direct participant of oxidative stress [36] . Low concentration of ROS is permanently produced in cells, which plays a role as signal molecules. Researches show that ROS participate in the production of many inflammatory cytokines by the different signal pathways such as MAPK and NF-κB [37, 38] . In the study, we found that FPA stimulated the production of superoxide anion in VSMCs, and the NADPH oxidase inhibitor DPI, mitochondrial respiratory complex II inhibitor TTFA and antioxidant NAC all inhibited FPA-induced the generation of superoxide anion in VSMCs, suggesting that the NADPH oxidase pathway and mitochondria-derived signal pathway are involved in FPA-elicited ROS generation. The abnormal generation of ROS plays important role in CRP expression, and this has been proved in many kinds of cell lines or tissues such as VSMCs [13] , endothelial cells [39] , liver cells [40] and macrophages [41] . The present study exhibited that antioxidant NAC abolished CRP expression induced by FPA, demonstrating that ROS mediate FPA-induced CRP expression in VSMCs.
MAPK is activated in the inflammatory process of atherosclerosis. ROS are able to regulate MAPK pathway involved in inflammatory process [42, 43] .The current experiment showed that FPA increased the expressions of phosphorylated ERK1/2 and p38 in vivo and in vitro, and ERK1/2 inhibitor PD98059 and p38 inhibitor SB203580 reduced FPA-induced CRP expression in vitro, implicating that the activated ERK1/2 and p38 participate in FPAinduced CRP production. However, JNK inhibitor SP600125 did not significantly affect FPAinduced CRP expression. In order to understand the roles of ROS in the inflammatory process, we detected the effect of the ROS scavenger NAC on the activation of ERK1/2 and p38. The results show that antioxidant NAC reduced the expressions of the phosphorylated ERK1/2 and p38. Collectively, these confirm that ROS are the upstream molecules of ERK1/2/p38 and regulate ERK1/2/p38 activation, and FPA induces CRP expression via the ROS-ERK1/2/ p38 signal pathway. But, we do not rule out other signal pathways mediating FPA-induced CRP expression, since ERK1/2 and p38 inhibitors partially inhibited FPA-induced CRP expression.
The existed evidence certifies that MAPK may activate NF-κB [44] . NF-κB activation regulates the generation of mediators resulting in the thrombotic potential of human
